View in EDS HTML Full Text PDF Full Text

Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study.

Saved in:
Bibliographic Details
Title: Evaluation of potential biomarkers during irinotecan-based systemic treatment for colorectal cancer—study protocol of the OPTIMA study.
Authors: Russ, E.1,2 (AUTHOR), Ziemons, J.1,2 (AUTHOR), Hillege, L. E.1,2 (AUTHOR), van Kuijk, S. M. J.3 (AUTHOR), de Jong, E. M.2,4 (AUTHOR), Elbers, C.5,6,7 (AUTHOR), Deenen, M. J.8,9 (AUTHOR), Borghuis, L. H.5,6,7 (AUTHOR), Böhm, T. M. M.8,9 (AUTHOR), Kristen, P.1,2 (AUTHOR), Valk, L. C.10 (AUTHOR), van Hellemond, I. E. G.11 (AUTHOR), Vestjens, H.12 (AUTHOR), Dietvorst, A.13 (AUTHOR), Baars, A.14 (AUTHOR), Goosens, A. N. M.15 (AUTHOR), Vermeulen, L.5,6,7 (AUTHOR), Buffart, T. E.7,16 (AUTHOR), de Vos-Geelen, J.1,17 (AUTHOR), Penders, J.18,19 (AUTHOR)
Source: BMC Cancer. 7/1/2025, Vol. 25 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-025-14500-6